Matthew Splett

The college’s investigators earned $19.4 million in NIH awards in 2025, according to the Blue Ridge Institute for Medical Research.

The University of Florida’s Office of Strategic Communications and Marketing selected a paper authored by Maddalena Parafati, Ph.D., research assistant professor of cellular and systems pharmacology in the UF College of Pharmacy, for its Research Promotion Initiative funding. The highly competitive contest awards $1,000 for accepted research highlighting important…

The Goodman and Gilman Award is presented biennially by the American Society for Pharmacology and Experimental Therapeutics, and Burris is the 24th recipient of this honor.

Nearly 100 scientists, industry leaders and government partners convened for the University of Florida’s second annual Biomanufacturing in Space Symposium on Nov. 6 in Orlando.

A new study led by UF researcher Siobhan Malany, Ph.D., sheds light on how human biology changes in microgravity.

A study supported by Dr. Jay McLaughlin aims to accelerate the drug development timeline for enhanced version of naloxone.

Using mouse models, Dr. Marco Bortolato and his lab showed in Molecular Psychiatry that CELSR3, a high-confidence risk gene for Tourette syndrome, leads to tic-like behaviors by altering the distribution of dopamine D3 receptors. These data point to D3 receptors as a promising therapeutic target in Tourette syndrome.

ACS Chemical Neuroscience chose artwork from Dr. Leslie Sombers’ latest publication to appear on the journal’s cover.

The agreement aims to foster international collaboration in space research, in-space manufacturing and space-related workforce development.

This prestigious honor recognizes Burris for his innovative research in nuclear receptor biology and its impact on therapeutic development.